Cargando…

How to deal with hypertension in the COVID-19 era—the impact “ON” and “OF” hypertension

Detalles Bibliográficos
Autor principal:	Ishida, Mari
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Singapore 2021
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8680064/ https://www.ncbi.nlm.nih.gov/pubmed/34921300 http://dx.doi.org/10.1038/s41440-021-00822-y

Ejemplares similares

Anxiety and hypertension in the COVID-19 era: how is the central autonomic network linked?
por: Nagai, Michiaki, et al.
Publicado: (2022)

Impact of the COVID-19 pandemic on physical and psychological activities in elderly patients with hypertension
por: Azushima, Kengo, et al.
Publicado: (2022)

Resistant hypertension and COVID-19: tip of the iceberg?
por: Tadic, Marijana, et al.
Publicado: (2021)

COVID-19 and hypertension: risks and management. A scientific statement on behalf of the British and Irish Hypertension Society
por: Clark, Christopher E., et al.
Publicado: (2021)

Double dealing
Publicado: (1997)

Hypertension, renin–angiotensin–aldosterone system inhibition, and COVID-19
por: Williams, Bryan, et al.
Publicado: (2020)

Severe COVID-19 and preexisting hypertension: a matter of age?
por: Yamazaki, Osamu, et al.
Publicado: (2022)

Diagnosis of EVALI in the COVID-19 era
por: Kazachkov, Mikhail, et al.
Publicado: (2020)

Offline: Science and politics in the era of COVID-19
por: Horton, Richard
Publicado: (2020)

Participant stress in the COVID-19 era and beyond
por: Goldfarb, Elizabeth V.
Publicado: (2020)

Prioritisation of COVID-19 boosters in the omicron era
por: Irving, Stephanie A, et al.
Publicado: (2022)

Is aberrant CD8+ T cell activation by hypertension associated with cardiac injury in severe cases of COVID-19?
por: Zhang, Chao, et al.
Publicado: (2020)

Challenges and opportunities to end tuberculosis in the COVID-19 era
por: Wingfield, Tom, et al.
Publicado: (2021)

Management of mother–newborn dyads in the COVID-19 era
por: Medvedev, Melissa M
Publicado: (2020)

Bringing research directly to families in the era of COVID-19
por: Balevic, Stephen J., et al.
Publicado: (2020)

HIV, tuberculosis, and malaria: how can the impact of COVID-19 be minimised?
por: Sands, Peter
Publicado: (2020)

A small contribution to mitigate the collision of transmissible and chronic diseases, exemplified by the management of hypertension during the COVID-19 pandemic
por: Valdés, Gloria, et al.
Publicado: (2020)

Functional status in the COVID-19 era: ALERT, ALERT, ALERT!
por: Marques, A.
Publicado: (2021)

Disease surveillance for the COVID-19 era: time for bold changes
por: Morgan, Oliver W, et al.
Publicado: (2021)

Social license for the use of big data in the COVID-19 era
por: Shaw, James A., et al.
Publicado: (2020)

Mental health of health-care workers in the COVID-19 era
por: Greenberg, Neil
Publicado: (2020)

Early immunomodulators with CAR T-cell immunotherapy in the COVID-19 era
por: Abid, Muhammad Bilal
Publicado: (2022)

Fitness and reduced risk of hypertension—approaching causality
por: Laukkanen, Jari A., et al.
Publicado: (2021)

Dealing with a new disease
por: Pinto, Y. M.
Publicado: (2022)

Neurological manifestations of rhino-oculo-cerebral mucormycosis in the COVID-19 era
por: Singh, Gagandeep, et al.
Publicado: (2021)

Cancer diagnostic delay in the COVID-19 era: what happens next?
por: Hamilton, William
Publicado: (2020)

Kawasaki disease in the COVID-19 era: a distinct clinical phenotype?
por: Kam, Kai-Qian, et al.
Publicado: (2020)

How outbreaks in different settings contribute to the transmission of SARS-CoV-2 in the era of “living with COVID”: the case of Japan
por: Leung, Char, et al.
Publicado: (2023)

Interleukin-6 inhibitors in non-COVID-19 ARDS: analyzing the past to step into the post-COVID-19 era
por: Gandini, Lucia, et al.
Publicado: (2023)

Resistance of children to Covid-19. How?
por: Fischer, Alain
Publicado: (2020)

Genomics in the era of COVID-19: ethical implications for clinical practice and public health
por: Geller, Gail, et al.
Publicado: (2020)

Restrictive abortion laws, COVID-19, telehealth, and medication abortion in the SDG era
por: Awowole, Ibraheem O, et al.
Publicado: (2022)

Melatonin as a rational alternative in the conservative treatment of resistant hypertension
por: Simko, Fedor, et al.
Publicado: (2019)

Influenza vaccination and interruption of methotrexate in adult patients in the COVID-19 era: an ongoing dilemma
por: Mehta, Puja, et al.
Publicado: (2021)

Retraction in the era of COVID-19 and its influence on evidence-based medicine: is science in jeopardy?
por: Boschiero, Matheus Negri, et al.
Publicado: (2021)

The UK Coronavirus Cancer Monitoring Project: protecting patients with cancer in the era of COVID-19
Publicado: (2020)

Urinary biomarkers to mitigate diagnostic delay in bladder cancer during the COVID-19 era
por: Ng, Kenrick, et al.
Publicado: (2020)

The growing threat of wild poliovirus 1 and vaccine-derived cases in the COVID-19 era
por: Franco-Paredes, Carlos, et al.
Publicado: (2022)

Revisiting the diagnosis of ‘resistant hypertension’: what should we do nowadays’
por: Alsharari, Reem, et al.
Publicado: (2021)

Hypertensive and cognitive function: did we come to a dead end?
por: Tadic, Marijana, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_o1m7s5rklltjju923cnoqolhdt